Calmare Therapeutics
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1375 Kings Hwy Ste 400, Fairfield, Conne...Phone Number
(203) 368-6044Website
www.calmaretherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Calmare Therapeutics
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 1968. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield,...Explore more
Calmare Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calmare Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Calmare Therapeutics recently announced quarterly report
Click to see if Calmare Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Calmare Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Calmare Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Calmare Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Calmare Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Calmare Therapeutics
Check if Calmare Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Calmare Therapeutics
Find more new buyers
Compare Similar Companies to Calmare Therapeutics
Compare insights from companies similar to Calmare Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Calmare Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Calmare Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Calmare Therapeutics.
Calmare Therapeutics Tech Stack
A closer look at the technologies used by Calmare Therapeutics
See more technologies
Calmare Therapeutics News & Media
Calmare Therapeutics Receives Two Favorable Rulings In Delaware Chancery Court
FAIRFIELD, CT / ACCESSWIRE / March 25, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC), the pain mitigation company ("Calmare" or the "Company"), announced today that, on March 15, 2019, Calmare won two significant rulings from the Delaware Court of Chancery brought against it and certain of its directors by Stanley Yarbro, another director. The Delaware Court rejected Yarbro's motion for a summary judgment to declare that he had been successful in a Consent ProxyCalmare Therapeutics Has $10.4 Million Judgment Vacated by The U.S. Court of Appeals for The Second Circuit
FAIRFIELD, CT / ACCESSWIRE / March 19, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC) (''CTI''), the pain mitigation company (''Calmare''), had a $10.4 million judgment vacated by the United States Court of Appeals for the Second Circuit (the ''Second Circuit''). On September 29, 2017, the U.S. District Court for the District of Connecticut (the ''District Court'') entered a final judgment awarding GEOMC Co., Ltd. - a South Korea corporation - monetary damages of $4,673,406Calmare Therapeutics Alerts All Shareholders of Inaccurate Information About the Company
Calmare's Board and Management Remain in Place FAIRFIELD, CT / ACCESSWIRE / February 16, 2018 / Calmare Therapeutics Incorporated (OTC PINK: CTTC), the pain mitigation company ("Calmare" or the "Company"), alerts all shareholders about inaccurate information that has been disseminated regarding the Company. On Friday, February 9, 2018, a complaining group of stockholders filed with the U.S. Securities and Exchange Commission ("SEC") statements alleging that all but one of Calmare's directors had
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calmare Therapeutics
Sign Up For FreeTo access detailed company insights
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pa... Read More
